Replies to post #111527 on Regen BioPharma Inc (RGBP)

[StocktonCA]

This could easily be bought out for 5+ dollars a share then institutions could run it up past $30/share. it may look impossible, but this company holds the only known key to unlocking the door to Curing CANCER!!! LET THAT SINK IN.

The big picture is the only picture that need be looked at!!

Hold on tight for the ride RGBP LONGS!!

[twaflyer1]

rgbp... OTC, there is a good probability that Lilly will hold off buying anything for a while after that debacle? Heads may be rolling and new conditions set into place? If that failure is due to intrinsic difficulties in the mRNA method, then they might not trust that method any more?

Also, remember that the mRNA vaccine for Covid has been problematic as time went on, so there might be general distrust of the method? At least this time, the mRNA cancer vaccine trial that we are conducting is going to get a thorough going over before it is granted a success! Of course, there are differences in the usage of mRNA, with RGBP's method seems not to be as GENE INVASIVE as the Covid vaccine, so that just might put us in a good position? Of course that is my layman opinion!! GLTA...